BridgeBio Pharma, Inc.

BBIO · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $13.3B · 839 employees
143
SEC Filings
$76.59
Close 2026-08-31
839
Employees

Business Summary

BridgeBio Pharma is a commercial-stage biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with genetic diseases. It operates a decentralized hub-and-spoke model and has received FDA approval for three products: Attruby (acoramidis) for ATTR-CM, Nulibry (fosdenopterin) for MoCD Type A, and Truseltiq (infigratinib) for cholangiocarcinoma (withdrawn). Attruby generated $362.4 million in U.S. net product revenues in 2025. The company also has multiple Phase 3 programs in achondroplasia, LGMD2I/R9, and ADH1.

Latest Stock Quote

BBIO 2026-08-31 $76.59 O:$76.2 H:$77.235 L:$75.02 Vol:2.1M VWAP:$76.1918
origin leaf: null

Next Earnings

expected 2026-11-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001743881-26-000009EDGAR152K words
2025-02-202024-12-310000950170-25-024119EDGAR159K words
2024-02-222023-12-310000950170-24-018811EDGAR147K words
2023-02-232022-12-310000950170-23-004145EDGAR149K words
2022-02-252021-12-310000950170-22-002030EDGAR—
2021-02-252020-12-310001564590-21-008969EDGAR—
2020-03-032019-12-310001564590-20-008260EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-102026-06-300001743881-26-000027EDGAR97K words
2025-10-292025-09-300001743881-25-000012EDGAR50K words
2025-08-052025-06-300000950170-25-103192EDGAR55K words
2025-04-292025-03-310000950170-25-060314EDGAR48K words
2024-11-122024-09-300000950170-24-124577EDGAR57K words
2024-08-012024-06-300000950170-24-089326EDGAR51K words
2024-05-022024-03-310000950170-24-052165EDGAR44K words
2023-11-022023-09-300000950170-23-058255EDGAR48K words
2023-08-032023-06-300000950170-23-037977EDGAR47K words
2023-05-042023-03-310000950170-23-017812EDGAR42K words
2022-11-032022-09-300000950170-22-021936EDGAR—
2022-08-042022-06-300000950170-22-014824EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-310001140361-26-035055EDGAR1K words
2026-08-170001140361-26-033282EDGAR1K words
2026-08-100001743881-26-000026EDGAR7K words
2026-07-220001140361-26-029291EDGAR2K words
2026-03-300001140361-26-011991EDGAR1K words
2026-02-240001743881-26-000008EDGAR7K words
2026-02-120001140361-26-004995EDGAR2K words
2026-01-210001140361-26-001843EDGAR2K words
2026-01-120001140361-26-000971EDGAR6K words
2025-10-290001140361-25-039705EDGAR2K words

143 total filings indexed. 114 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

transthyretin-amyloid-cardiomyopathy-(attr-cm) rare-genetic-diseases achondroplasia limb-girdle-muscular-dystrophy autosomal-dominant-hypocalcemia chronic-hypoparathyroidism molybdenum-cofactor-deficiency cholangiocarcinoma

Company Identity

CIK0001743881
TickerBBIO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.bridgebio.com
Listed2019-06-27

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 789b47c91486334a8d5d329b5896a0ee7a469fa338a17be580ed8e8eafb98215
parent: 42adb20f4f04f596d8041122f3ffe9881d902105aa798daba8a3925fbaa9dc41
content hash: 2b958e96f8dd34be0fb738a582b08dc32c43b8955a980f8e4a28df2853e5f31e
signed: 2026-09-29T19:00:25.975Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BBIO using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BBIO, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BBIO (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.